These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 1088916

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG, Hollifield JW, Liddle GW.
    JAMA; 1974 Feb 04; 227(5):518-21. PubMed ID: 4589187
    [No Abstract] [Full Text] [Related]

  • 23. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L, Waeber B, Brunner HR.
    Schweiz Med Wochenschr; 1983 Mar 05; 113(9):331-8. PubMed ID: 6342133
    [Abstract] [Full Text] [Related]

  • 24. [Antihypertensive action and tolerance of alphamethyldopa and hydrochlorothiazide in fixed association versus single alphamethyldopa administration].
    Capuano V, De Martino M, Desiderio G, Riccio MD, De Vita S, Mondillo G.
    G Clin Med; 1984 Mar 05; 65(7-8):367-74. PubMed ID: 6500213
    [No Abstract] [Full Text] [Related]

  • 25. The effects of antihypertensive therapy on the quality of life.
    Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH.
    N Engl J Med; 1986 Jun 26; 314(26):1657-64. PubMed ID: 3520318
    [Abstract] [Full Text] [Related]

  • 26. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM, Suthers MB, Friedman A, Johnston CI.
    Med J Aust; 1978 May 06; 1(9):509-12. PubMed ID: 353458
    [Abstract] [Full Text] [Related]

  • 27. [Effect of hydrochlorothiazide and methyldopa on lipid metabolism in patients with essential hypertension].
    Mion Júnior D, Quintão EC, Nakamoto F, Castilho LN, Andriolo A, Marcondes M.
    AMB Rev Assoc Med Bras; 1988 May 06; 34(2):41-3. PubMed ID: 3072596
    [No Abstract] [Full Text] [Related]

  • 28. [Whether treatment of hypertension in elderly patients is necessary: a European study (author's transl)].
    Laaser U, Amery A, Meurer KA, Kaufmann W.
    Med Klin; 1978 Jan 20; 73(3):89-95. PubMed ID: 622062
    [No Abstract] [Full Text] [Related]

  • 29. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL.
    Curr Ther Res Clin Exp; 1974 Nov 20; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS, Allard PP, Wilson M, Orbeck KW, Helman AB, Lefebvre R.
    Clin Invest Med; 1978 Nov 20; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract] [Full Text] [Related]

  • 31. Oral enalapril-hydrochlorothiazide-methyldopa as first line treatment for severe hypertension in Nigerians.
    Ofor OO.
    Trop Doct; 2004 Jan 20; 34(1):32-3. PubMed ID: 14959973
    [Abstract] [Full Text] [Related]

  • 32. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF, Kulaga SF, Kramsch DM.
    J Hypertens Suppl; 1984 Dec 20; 2(2):S107-11. PubMed ID: 6100871
    [Abstract] [Full Text] [Related]

  • 33. Methyldopa in the elderly hypertensive.
    MacFarlane JP.
    Curr Med Res Opin; 1982 Dec 20; 7(Suppl 1):63-7. PubMed ID: 7049582
    [Abstract] [Full Text] [Related]

  • 34. The effect of a single daily low dose of methyldopa and K+ sparing diuretic on blood pressure in the elderly.
    Fidel J, Glikberg F.
    Br J Clin Pract; 1988 Dec 20; 42(12):491-4. PubMed ID: 3256343
    [No Abstract] [Full Text] [Related]

  • 35. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M.
    Ugeskr Laeger; 1973 May 17; 135(20):974-6. PubMed ID: 4585571
    [No Abstract] [Full Text] [Related]

  • 36. Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension. ATHES Study Group.
    Genthon R.
    Int J Clin Pharmacol Res; 1994 May 17; 14(1):1-9. PubMed ID: 7927956
    [Abstract] [Full Text] [Related]

  • 37. [The combination of hydrochlorothiazide, amiloride and alpha-methyldopa in the treatment of arterial hypertension. Clinical evaluation of a multicentric study].
    Masacci E, Montemartini C, Bobba P, Croce L, Ricciardi S, Mussari A, Bernardi P, Dalla Torre M, Di Benedetto A, Santucci F, Lombardo M, Galassi A.
    Minerva Cardioangiol; 1979 Dec 17; 27(12):801-6. PubMed ID: 550094
    [No Abstract] [Full Text] [Related]

  • 38. [Results of a national therapeutic trial in 10,000 hypertensive patients conducted by 2000 general practitioners (author's transl)].
    Jouve A, Goldet L, Mathieu M.
    Sem Hop; 1979 Dec 17; 54(43-44):1363-8. PubMed ID: 219491
    [Abstract] [Full Text] [Related]

  • 39. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide.
    Jones DW, Sands CD.
    Pharmacotherapy; 1991 Dec 17; 11(2):127-30. PubMed ID: 2052467
    [Abstract] [Full Text] [Related]

  • 40. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK, Russell RP, Sova-Schulz K, Wyndham R, Walker WG.
    J Cardiovasc Pharmacol; 1979 Dec 17; 1(6 Suppl):S28-37. PubMed ID: 94637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.